Visual Outcomes Of The Rayone Galaxy Spiral Intraocular Lens Implant
Published 2025 - 43rd Congress of the ESCRS
Reference: FP05.10 | Type: Free paper | DOI: 10.82333/5z5h-ar31
Authors: Clare O'Donnell* 1 , Amir Hamid 2 , Alise Kalteniece 2 , Nabila Jones 2
1Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom;Faculty of Biology, Medicine and Health,University of Manchester,Manchester,United Kingdom;College Health Life Sciences,Aston Universtity,Birmingham,United Kingdom, 2Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom
Purpose
The RayOne Galaxy spiral intraocular lens implant (IOL) has been designed to deliver a full range of vision with minimised dysphotopsia achieved through a non-diffractive spiral optic for 0% light loss. This retrospective case series was performed to assess the real-world visual outcomes of the RayOne Galaxy IOL in eyes undergoing refractive lens exchange (RLE) and cataract surgery.
Setting
Multiple centre, single surgeon, private practice, London, UK.
Methods
Eyes implanted with the RayOne Galaxy IOL during cataract surgery or refractive lens exchange were identified between 08/10/2024 and 11/02/2025. Eyes with sufficient visual and refractive data were included in the study. Follow up data ranged from 6 weeks to 4 months post-operatively. All surgeries were carried out by a single surgeon.
Results
51 eyes of 26 patients were implanted with Galaxy IOLs (25 bilateral cases). 42 eyes had toric IOLs implanted. 11 males and 15 females with a mean age of 60 years (range 34-76) were included. 34 eyes underwent RLE and 17 eyes cataract surgery.
Mean binocular UDVA was -0.10 (±0.05) LogMAR and unilateral UDVA -0.05 (±0.06) LogMAR. Mean binocular UIVA was 0.06 (±0.06) LogMAR and unilateral UIVA 0.11 (±0.07) LogMAR. Mean binocular UNVA was 0.17 (±0.05) LogMAR and unilateral UNVA 0.20 (±0.05) LogMAR. Mean spherical equivalent refraction was -0.01 (±0.26) Dioptres (D), with mean deviation of attempted spherical equivalent of -0.16 (±0.27) D. 10 eyes required YAG laser posterior capsulotomy. Haloes were graded mild by 22 and moderate by 4 patients.
Conclusions
The new generation Rayone Galaxy spiral IOL provides an excellent range of unaided vision for distance, intermediate and near, with well tolerated levels of dysphotopsia. Targeting the first plus when aiming for plano achieved a refractive outcome within 0.25 D for 82.4% of this cohort. Optimisation of the IOL A-constant is recommended to successfully achieve emmetropia. YAG laser within 4 months was beneficial for 19.6% of the cohort. Haloes were reported by all subjects, but these were predominantly mild and well tolerated. The Galaxy IOL represents an excellent solution for patients requiring a full range of vision with reduced dysphotopsias. A period of neuro-adaptation is required and patients should be counselled accordingly.